Medha Jaimini Gunaratna

Dr. Medha Jaimini Gunaratna

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2021 in Molecules
Verified
Journal Article
Open access
PDF file
IKIshani Kalatuwawege
Ishani Kalatuwawege
MGMedha Jaimini Gunaratna
Medha Jaimini Gunaratna
DUDinusha Nishani Udukala
Dinusha Nishani Udukala
Gastrointestinal tract infection caused by Helicobacter pylori is a common virulent disease found worldwide, and the infection rate is much higher in developing countries than in developed ones. In the pathogenesis of H. pylori in the gastrointestinal tract, the secretion of the urease enzyme plays a major role. Therefore, inhibition of urease is a better approach against H. pylori infection. In the present study, a series of syn and anti isomers of N-substituted indole-3-carbaldehyde oxime derivatives was synthesized via Schiff base reaction of appropriate carbaldehyde derivatives with hydroxylamine hydrochloride. The in vitro urease inhibitory activities of those derivatives were evaluated against that of Macrotyloma uniflorum urease using the modified Berthelot reaction. Out of the tested compounds, compound 8 (IC50 = 0.0516 ± 0.0035 mM) and compound 9 (IC50 = 0.0345 ± 0.0008 mM) were identified as the derivatives with potent urease inhibitory activity with compared to thiourea (IC50 = 0.2387 ± 0.0048 mM). Additionally, in silico studies for all oxime compounds were performed to investigate the binding interactions with the active site of the urease enzyme compared to thiourea. Furthermore, the drug-likeness of the synthesized oxime compounds was also predicted.

18 February 2025 in ACS Omega
Verified
Journal Article
Open access
RJRashmi N. Jayasinghe
Rashmi N. Jayasinghe
NDNawanjana T. Padukkage Dona
Nawanjana T. Padukkage Dona
VHVisal C. Lorensu Hewage
Visal C. Lorensu Hewage
NENishal M. Egodawaththa
Nishal M. Egodawaththa
NNNasri Nesnas
Nasri Nesnas
MGMedha Jaimini Gunaratna
Medha Jaimini Gunaratna
Oxazolones are heterocyclic molecules characterized by a five-membered ring containing both nitrogen and oxygen atoms. It is a significant pharmacophore for therapies as well as a synthon for many physiologically active compounds. Since diabetes is a chronic disease that affects how the body metabolizes sugars, the major focus of this study was to evaluate the antidiabetic properties of synthetic 4-( Hydroxysubstituted arylidene)-2-phenyloxazol-5(4 H )-one derivatives in silico and in vitro. Derivatives were synthesized by the Erlenmeyer and Justus method with slight modifications. Structures of the derivatives were confirmed by physical, FTIR, 1H NMR, 13C NMR, and HRMS data. Mainly, the antidiabetic properties were determined via α-amylase inhibitory activity, α-glucosidase inhibitory activity, glycation inhibitory activity, glucose uptake by yeast cell assay, and kinetic studies. The ability of synthesized compounds in the inhibition of α-amylase and α-glucosidase, drug-likeness model score evaluations, possible adverse effects, and ADMET profiles were also investigated by in silico studies. The results indicate that 5e exhibits the highest inhibition toward α-amylase enzyme with a mixed inhibition, while 5b showed the highest inhibition toward α-glucosidase enzyme with a mixed inhibition pattern in the presence of acarbose as the standard drug. In the protein glycation inhibitory assay, 5e demonstrated strong inhibition at higher concentrations, surpassing quercetin. Maximum potential to transport glucose across the cell membrane of Saccharomyces cerevisiae was shown by 5e. Under in silico studies, 5e showed the highest drug-likeness score and the highest affinity for the α-amylase enzyme, while 5d showed the highest affinity toward the α-glucosidase enzyme. These results show a good correlation between in vitro and in silico studies for 5e. Overall, results from both in vitro and in silico studies suggest that the increment of the number of hydroxyl groups in the structure may enhance the activity of 5e and the potential of synthesized oxazol-5(4H)-one derivatives with hydroxyl groups attached to the phenyl ring as promising candidates for the treatment of diabetic mellitus. Further, it suggests that more research is required to validate the efficacy and mechanisms of action of these compounds.

12 January 2019 in Arkivoc
Verified
Journal Article
Open access
MGMedha Jaimini Gunaratna
Medha Jaimini Gunaratna
DHDuy Hua
Duy Hua
BZBende Zou
Bende Zou
CPConrado Pascual
Conrado Pascual
WCWilliam Cao
William Cao
XXXinmin Xie
Xinmin Xie

25 July 2024 in Asian Journal of Chemistry
Verified
Journal Article
Open access
PDF file
VHVisal C. Lorensu Hewage
Visal C. Lorensu Hewage
MGMedha Jaimini Gunaratna
Medha Jaimini Gunaratna
NENishal Madujith Egodawaththa
Nishal Madujith Egodawaththa
NNNasri Nesnas
Nasri Nesnas
In this study, four different 4-arylidene-2-phenyloxazol-5(4H)-ones (5a-d), were synthesized via the Erlenmeyer-Plöchl reaction and characterized by FT-IR, 1H NMR, 13C NMR and mass spectroscopic techniques. Evaluation of their in vitro anti-inflammatory activities using the heat-induced human red blood cell (HRBC) membrane stabilization assay revealed concentration dependent inhibitory effects. The IC50 values of 5a, 5b, 5c and 5d were reported as 4.65 ± 0.22 mM, 7.34 ± 0.28 mM, 5.23 ± 0.18 mM and 1.96 ± 0.09 mM, respectively. O-Acetyl salicylic acid as standard showed its IC50 value at 6.41 ± 0.18 mM. Docking studies against human cyclooxygenase (COX) 1 and 2 revealed affinities of the compounds to binding cavities of COX enzymes. Particularly, compound 5d exhibited remarkable activity in both HRBC membrane stabilization and the formation of hydrogen bonds with binding cavities. This suggests a potential correlation between the number of hydroxyl groups of oxazolone derivatives and the enhancement of anti-inflammatory activity.

1 January 2024 in Medicinal Plants - International Journal of Phytomedicines and Related Industries
Verified
Journal Article
Closed access
PDF file
KEK.S.J. Ekanayaka
K.S.J. Ekanayaka
MGMedha Jaimini Gunaratna
Medha Jaimini Gunaratna
MNM.L.F. Nusfa
M.L.F. Nusfa
The fruit rind of Garcinia quaesita Pierre is known as a condiment with therapeutic potential, including antioxidant, antihyperglycemic, and anti-proliferative effects. However, there has been a lack of in-depth investigation into its phytochemical composition and its activities related to anti-inflammatory, and anti-tyrosinase activities. In this study a 1:1 ethanol : water extract of fresh fruit of Garcinia quaesita was used. Preliminary phytochemical screening revealed the presence of numerous bioactive compounds, including alkaloids, polyphenols, flavonoids, glycosides, coumarins, anthraquinones, steroids, terpenoids, saponin, and xanthoproteins. The Total Phenolic Content (TPC) of the fruit extract of G. quaesita was 3053.25 ± 30.07 μg GAE g−1, and Total Flavonoid Content (TFC) was 443.19 ± 4.76 μg CE g−1. The extract exhibited moderate antioxidant activity (IC50 238.14 ± 0.68 μg mL−1) compared to ascorbic acid. In anti-inflammatory assays, compared to O-acetyl salicylic acid, the extract showed notably higher inhibitory effects against egg albumin denaturation and heat-induced hemolysis with lower IC50 values of 762.49 ± 1.70 μg mL−1 and 617.66 ± 1.75 ìg mL−1 respectively. Correlation analysis highlighted strong positive correlations between TPC and antioxidant (r=0.801) and anti-inflammatory (r=0.725 and r=0.605) activities, highlighting the role of TPC. At 4 mg mL−1, the fruit extract of Garcinia quaesita Pierre exhibited lower inhibitory activity of tyrosinase with an IC50 value of 3.31 ± 0.04 mg mL−1, than kojic acid. Additionally, the SPF value at 2 mg mL−1 was 15, indicating moderate UV protection. In conclusion, this study suggests the potential use of fresh G. quaesita fruit extract for functional foods and cosmetics, owing to its rich phytochemical composition and bioactivities, especially in antioxidative and anti-inflammatory domains.

10 August 2026 in Applied Biosciences
Verified
Journal Article
Open access
PDF file
WJWushan T. Jayalath
Wushan T. Jayalath
MGMedha Jaimini Gunaratna
Medha Jaimini Gunaratna
CKChamila Chathuranga Kadigamuwa
Chamila Chathuranga Kadigamuwa
CTCharitha Thambiliyagodage
Charitha Thambiliyagodage
JDJayangika Dahanayake
Jayangika Dahanayake
Globally, over 55 million people are affected by Alzheimer’s disease (AD), a number that is increasing rapidly and projected to triple by 2050. AD is a type of neurodegenerative disorder for which there is no curative treatment. The accumulation of amyloid-β (Aβ) plaques and the formation of neurofibrillary tangles are the hallmarks of AD. Curcumin, a bioactive compound extracted from turmeric rhizomes, has shown significant neuroprotective properties, including anti-amyloidogenic, anti-inflammatory, antioxidant, and metal-chelating. Though much research has revealed the potential of curcumin as a promising therapeutic agent for AD, the limited bioavailability of curcumin restricts its effectiveness in pharmaceutical applications. To overcome this challenge, nanocarrier-based delivery systems have emerged as a promising strategy for enhancing the bioavailability and therapeutic efficacy of curcumin. This review provides an overview of recent findings on curcumin-based nanocarriers for AD therapy.